Literature DB >> 11172741

Differential induction of stearoyl-CoA desaturase and acyl-CoA oxidase genes by fibrates in HepG2 cells.

C Rodríguez1, A Cabrero, N Roglans, T Adzet, R M Sánchez, M Vázquez, C J Ciudad, J C Laguna.   

Abstract

We studied whether two typical effects of fibrates, induction of stearoyl-CoA desaturase (EC 1.14.99.5) and peroxisome proliferation, are related. The effect of bezafibrate on the activity and mRNA of stearoyl-CoA desaturase and acyl-CoA oxidase in the liver and epididymal white adipose tissue of male Sprague-Dawley rats was determined. The same parameters were measured in HepG2 cells, a cell line resistant to peroxisome proliferation, following incubation with ciprofibrate. Bezafibrate increased the hepatic mRNA levels (14.5-fold on day 7) and activity (9.3-fold on day 15) of acyl-CoA oxidase. Stearoyl-CoA desaturase mRNA levels were transiently increased (2.7-fold on day 7), while its activity remained increased at the end of the treatment (2.4-fold). In white adipose tissue, bezafibrate increased the mRNA (5-fold) and activity (1.9-fold) of acyl-CoA oxidase, while stearoyl-CoA desaturase was not modified. Ciprofibrate addition to HepG2 cells cultured in 7% fetal bovine serum (FBS) only increased the stearoyl-CoA desaturase mRNA (1.9-fold). When cells were cultured in 0.5% FBS, ciprofibrate increased acyl-CoA oxidase mRNA (2.2-fold), while the increase in stearoyl-CoA desaturase mRNA was identical (1.9-fold). Further, its activity was also increased (1.5-fold). Incubation of HepG2 cells in the presence of cycloheximide did not alter the capacity of ciprofibrate to induce stearoyl-CoA desaturase mRNA, whereas the presence of actinomycin abolished the induction. In addition, preincubation of HepG2 cells with ciprofibrate increased the rate of stearoyl-CoA desaturase mRNA degradation. The results presented in this study suggest that fibrates induce stearoyl-CoA desaturase activity and mRNA levels independently of peroxisome proliferation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172741     DOI: 10.1016/s0006-2952(00)00557-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.

Authors:  Ana Soria; Maria del Carmen González; Hubert Vidal; Emilio Herrera; Carlos Bocos
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

2.  Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor alpha-deficient mice.

Authors:  Hervé Guillou; Pascal Martin; Sophie Jan; Sabine D'Andrea; Alain Roulet; Daniel Catheline; Vincent Rioux; Thierry Pineau; Philippe Legrand
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

3.  P465L-PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates.

Authors:  Sergio Rodriguez-Cuenca; Stefania Carobbio; Gwendolyn Barceló-Coblijn; Xavier Prieur; Joana Relat; Ramon Amat; Mark Campbell; Ana Rita Dias; Myriam Bahri; Sarah L Gray; Antonio Vidal-Puig
Journal:  Diabetes Obes Metab       Date:  2018-06-27       Impact factor: 6.577

4.  A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways.

Authors:  Zheng Li; Shireesh Srivastava; Sheenu Mittal; Xuerui Yang; Lufang Sheng; Christina Chan
Journal:  BMC Bioinformatics       Date:  2007-06-14       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.